[1] Lohmander LS, Englund PM, Dahl LL, et al. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis[J]. Am J Sports Med,2007,35(10):1756-1769.
[2] Spindler KP, Wright RW. Clinical practice. Anterior cruciate ligament tear[J]. N Engl J Med, 2008, 359(20):2135-2142.
[3] Griffin LY, Agel J, Albohm MJ, et al. Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies[J]. J Am Acad Orthop Surg, 2000, 8(3):141-150.
[4] Anderson K, Seneviratne AM, Izawa K, et al. Augmentation of tendon healing in an intraarticular bone tunnel with use of a bone growth factor[J]. Am J Sports Med, 2001, 29(6):689-698.
[5] Sasaki K, Kuroda R, Ishida K, et al. Enhancement of tendon-bone osteointegration of anterior cruciate ligament graft using granulocyte colony-stimulating factor[J]. Am J Sports Med, 2008, 36(8):1519-1527.
[6] Kim JG, Kim HJ, Kim SE, et al. Enhancement of tendon-bone healing with the use of bone morphogenetic protein-2 inserted into the suture anchor hole in a rabbit patellar tendon model[J]. Cytotherapy, 2014, 16(6):857-867.
[7] Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned[J]. Spine J, 2011, 11(6):471-491.
[8] Lim JK, Hui J, Li L, et al. Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction[J]. Arthroscopy, 2004, 20(9):899-910.
[9] Kanaya A, Deie M, Adachi N, et al. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model[J]. Arthroscopy, 2007, 23(6):610-617.
[10] Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin[J]. Nat Cell Biol, 2001, 3(9):778-784.
[11] Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue[J]. Stem Cells, 2006, 24(5):1294-1301.
[12] Rodeo SA, Suzuki K, Deng XH, et al. Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel[J]. Am J Sports Med,1999, 27(4):476-488.
[13] Takigami J, Hashimoto Y, Yamasaki S, et al. Direct bone-to-bone integration between recombinant human bone morphogenetic protein-2-injected tendon graft and tunnel wall in an anterior cruciate ligament reconstruction model[J]. Int Orthop, 2015, 39(7):1441-1447.
[14] Zuk P A, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies[J]. Tissue Eng, 2001, 7(2):211-228.
[15] Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult stem cells produce osteoid in vivo[J]. Tissue Eng, 2004,10(3-4):371-380.
[16] Yoon E, Dhar S, Chun DE, et al. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model[J]. Tissue Eng, 2007, 13(3):619-627.
[17] Sheykhhasan M, Qomi RT, Ghiasi M. Fibrin scaffolds designing in order to human adipose-derived mesenchymal stem cells differentiation to chondrocytes in the presence of TGF-beta3[J]. Int J Stem Cells, 2015, 8(2):219-227.
[18] An C, Cheng Y, Yuan Q, et al. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells[J]. Ann Biomed Eng, 2010, 38(4):1647-1654.
[19] Jeon O, Rhie JW, Kwon IK, et al. In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically[J]. Tissue Eng Part A, 2008, 14(8):1285-1294.
[20] Karaoglu S, Celik C, Korkusuz P. The effects of bone marrow or periosteum on tendon-to-bone tunnel healing in a rabbit model[J]. Knee Surg Sports Traumatol Arthrosc, 2009,17(2):170-178. |